Furo[3,4-b]pyridin-5(7H)-one manufacturers
|
| | Furo[3,4-b]pyridin-5(7H)-one Basic information |
| Product Name: | Furo[3,4-b]pyridin-5(7H)-one | | Synonyms: | 4-AZAPHTHALIDE;FURO[3,4-B]PYRIDIN-5(7H)-ONE;5,7-dihydrofuro<3,4-b>pyridin-5-one;FURO[3,4-B]PYRIDIN-5(7H)-ONE/4-AZAPHTHALIDE;7H-furo[3,4-b]pyridin-5-one;azabenzenephthalazine | | CAS: | 5657-51-2 | | MF: | C7H5NO2 | | MW: | 135.12 | | EINECS: | 811-772-0 | | Product Categories: | | | Mol File: | 5657-51-2.mol | ![Furo[3,4-b]pyridin-5(7H)-one Structure](CAS/GIF/5657-51-2.gif) |
| | Furo[3,4-b]pyridin-5(7H)-one Chemical Properties |
| Melting point | 142-144 °C | | Boiling point | 330.9±37.0 °C(Predicted) | | density | 1.360±0.06 g/cm3(Predicted) | | storage temp. | Sealed in dry,Room Temperature | | pka | 1.81±0.20(Predicted) | | Appearance | White to off-white Solid |
| | Furo[3,4-b]pyridin-5(7H)-one Usage And Synthesis |
| Synthesis | General procedure for the synthesis of furan[3,4-B]pyridin-5(7H)-one from 2,3-pyridinedicarboxylic anhydride: NaBH4 (1.14 g, 33.5 mmol) was slowly added to a solution of tetrahydrofuran (THF, 35 mL) of 2,3-pyridinedicarboxylic anhydride (5.0 g, 33.5 mmol) under argon gas protection and the temperature of the reaction was kept at 15 °C. Subsequently, acetic acid (4 g, 67 mmol) was added dropwise and the reaction mixture was stirred continuously at 15 °C for 4 hours. Upon completion of the reaction, the solvent was removed by distillation under reduced pressure. The residue was dissolved in a mixture of acetic acid (13.5 mL) and acetic anhydride (13.5 mL) and stirred at 100 °C for 3 hours. The reaction mixture was concentrated under reduced pressure and the residue was dissolved in a mixed solution of water (35 mL) and sodium chloride (6.7 g). The aqueous phase was extracted with chloroform (3 x 40 mL) and the organic layers were combined and concentrated. Finally, recrystallization by isopropanol (z'-PrOH) afforded the target compound furan[3,4-B]pyridin-5(7H)-one (2.5 g, 55% yield) as a light yellow solid with a melting point of 123-125°C. The product was detected by IR (KBr), showing characteristic absorption peaks located at 1778, 1567, 1423, 1355, 1000, 743 cm^-1 ; 1H NMR (300 MHz, CDCl3) spectrum showed δ 8.87 (dd, J = 1.5, 4.9 Hz, 1H), 8.22 (dd, J = 1.5, 7.7 Hz, 1H), and 7.50 (dd, J = 5.0, 7.8 Hz, 1H), 5.33 (s, 2H); ESIMS analysis showed m/z 136 (MH+, relative intensity 100). | | References | [1] Journal of Medicinal Chemistry, 2009, vol. 52, # 6, p. 1778 - 1782 [2] Journal of Medicinal Chemistry, 2016, vol. 59, # 8, p. 3840 - 3853 [3] Patent: WO2017/160898, 2017, A1. Location in patent: Paragraph 00104; 00120 [4] Synthesis, 1997, # 1, p. 113 - 116 [5] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1981, p. 3012 - 3015 |
| | Furo[3,4-b]pyridin-5(7H)-one Preparation Products And Raw materials |
|